nafcillin has been researched along with warfarin in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Rihn, TL; Shovick, VA | 1 |
Berman, W; Davis, RL; Kelly, HW; Wernly, JA | 1 |
Fraser, GL; Kane, K; Miller, M | 1 |
Evans, HJ; Qureshi, GD; Reinders, TP; Somori, GJ | 1 |
Fletcher, JL; Goldstein, AO; Pritchard, DC; Taylor, AT | 1 |
Fowler, JW; Heilker, GM; Self, TH | 1 |
Epplen, K; Foruhari, F; Frey, RJ; Kim, KY | 1 |
Ali, A; Bechard, D; Jovin, IS; Kaszala, K; Khan, R; Raza, S | 1 |
3 review(s) available for nafcillin and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.
Topics: Adult; Aortic Valve; Dicloxacillin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Nafcillin; Prosthesis-Related Infections; Prothrombin Time; Warfarin | 1994 |
Interaction between warfarin and nafcillin: case report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Humans; International Normalized Ratio; Male; Nafcillin; Venous Thrombosis; Warfarin | 2007 |
10 other study(ies) available for nafcillin and warfarin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Decreased hypoprothrombinemic response to warfarin secondary to the warfarin-nafcillin interaction.
Topics: Aged; Drug Interactions; Humans; Hypoprothrombinemias; Male; Middle Aged; Nafcillin; Warfarin | 1991 |
Warfarin-nafcillin interaction.
Topics: Child; Drug Interactions; Female; Humans; Nafcillin; Prothrombin Time; Warfarin | 1991 |
Warfarin resistance associated with nafcillin therapy.
Topics: Adult; Drug Resistance; Female; Humans; Nafcillin; Prothrombin Time; Warfarin | 1989 |
Warfarin resistance with nafcillin therapy.
Topics: Adult; Blood Coagulation; Drug Interactions; Drug Resistance; Humans; Kinetics; Male; Nafcillin; Protein Binding; Serum Albumin; Warfarin | 1984 |
Possible nafcillin-warfarin interaction.
Topics: Aged; Drug Interactions; Female; Humans; Nafcillin; Prothrombin Time; Warfarin | 1994 |
Septic pulmonary embolism in a patient with defibrillator lead endocarditis.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Brachiocephalic Veins; Defibrillators, Implantable; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Furunculosis; Humans; Jaw; Jugular Veins; Male; Nafcillin; Pulmonary Embolism; Reoperation; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |